With lung cancer survival rates greatly improved by early detection, we've seen a number of efforts to develop a better way to detect the disease in its early stages. So-called lung cancer breathalyzers are one technology being developed by a number of research teams, including one from the University of Huddersfield in the UK, which plans to trial a breathalyzer device in pharmacies.
The project to develop the device, which is taking place over three years, involves researching a lung cancer "biomarker signature" that is detectable in breath. Previous studies have already shown that carbon-based sensors embedded with gold nanoparticles and even dogs can detect chemicals in the breath indicating the presence of the disease in the lungs.
Via Ray and Terry's